Table 2.
The incidence and hazard ratio of stroke in subjects with and without BPPV.
| Presence of ischemic stroke in maximal 9-year follow-up period |
Total subjects |
Without BPPV |
With BPPV |
|||
|---|---|---|---|---|---|---|
| Number | % | Number | % | Number | % | |
| Yes | 425 | 3.4 | 240 | 2.9 | 185 | 4.5 |
| No | 12058 | 96.6 | 8139 | 97.1 | 3919 | 95.5 |
| Crude hazard ratio (95% CI) | 1 | 1.708 (1.409 ~ 2.069)** | ||||
| Adjusted hazard ratio (95% CI) | 1 | 1.415 (1.162 ~ 1.723)* | ||||
**p < 0.001, *p = 0.001.
Adjustment was made for subjects’ age, gender, hypertension, diabetes, atrial fibrillation/flutter, hyperlipidemia, coronary artery disease, and medications including antiplatelets, coumadin, and statin.